Medicines & drugs recalls
909 recalls since January 2025 from Health Canada, FDA, newest first. Last notice 19 Nov 2026.
Page 13 of 19
- VIONA PHARMACEUTICALS INC recalls Tavaborole Topical Solution 5%FDADiscoloration
- The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Carvedilol Tablets USPFDACGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
- Important Safety Information on CRYSVITA (burosumab) and the Risk of Severe Hypercalcemia in Patients with Tertiary HyperparathyroidismHealth CanadaNew safety information - Product safety
- DRAXIMAGE SODIUM IODIDE I131 SOLUTION, USP DIAGNOSTIC: may contain an incorrect product monograph.Health CanadaProduct safety
- Ultra Albumin Gold: The addition of the medicinal ingredient albumin is not compliant with its market authorization.Health CanadaProduct safety
- Super Probiotics: Affected lot contains undeclared probiotic strains, zinc and selenium that may pose a risk to health.Health CanadaProduct safety
- Important Safety Information on COPAXONE (glatiramer acetate) and the Risk of Anaphylactic Reactions Which May Occur at Any Time Following Initiation of TreatmentHealth CanadaNew safety information - Product safety - Adverse reaction
- Super Germiphene & Oro Clense: missing lot and expiration date.Health CanadaProduct safety
- Merck & Co. Inc recalls Belsomra (suvorexant) tabletsFDAFailed Dissolution Specifications: potential for delayed dissolution of the dose after administration which may result in delayed release of the…
- Ascend Laboratories, LLC recalls Amlodipine and Olmesartan Medoxomil TabletsFDAFailed Dissolution Specifications: low dissolution results
- Pfizer recalls Levoxyl (levothyroxine sodium tabletsFDASubpotent drug
- Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release CapsulesFDACGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
- B BRAUN MEDICAL INC recalls .9% Sodium Chloride Injection USP and 1 moreFDALack of Assurance of Sterility; potential for fluid leakage at one of the weld sites.
- Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsFDACGMP Deviations: Presence of a nitrosamine, N-Nitroso Carvedilol I Impurity above the current Acceptable Intake Level.
- Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsFDACGMP Deviations: Results for N-Nitroso Carvedilol Impurity-1 (NNCI) impurity observed to be above the FDA-recommended limit of NMT 4.0 ppm
- Westminster Pharmaceuticals LLC recalls Metoprolol Tartrate TabletsFDACGMP Deviations: Presence of a nitrosamine, N-nitroso-metoprolol above the established Acceptable Daily Intake (ADI) level.
- Glenmark Pharmaceuticals Inc., USA recalls Theophylline extended-release tablets 400mgFDAFailed Dissolution Specifications: Failure results (above) were reported for the Dissolution (by UV) test for commercial annual stability at the…
- Wellness by London Drugs Hand Sanitizer Gel; Deficiencies in Good Manufacturing PracticesHealth CanadaProduct quality
- Terranueva Pharma Corporation recalls one lot of Nueva+ Le Fameux dried cannabis pre-rollsHealth CanadaLabelling and packaging
- Hybrid Infusions Ltd. recalls one lot of Charlotte’s Web Grape 5 x 0.5g Infused Pre-Rolls cannabis extractHealth CanadaLabelling and packaging
- Jamp Bisoprolol 5 mg tablet: may contain a foreign tabletHealth CanadaProduct quality
- Direct Rx recalls Duloxetine D/RFDACGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
- Breckenridge Pharmaceutical, Inc. recalls Duloxetine Delayed-Release CapsulesFDACGMP Deviations: Presence of N-nitroso-duloxetine impurity above safety assessment limit
- AEQUITA PHARMACY recalls Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol and 12 moreFDALack of Processing Controls.
- Alembic Pharmaceuticals Limited recalls Doxepin Hydrochloride CapsulesFDACGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
- Cardinal Health Inc. recalls RECOMBINATE and 1 moreFDACGMP Deviations - Product was exposed to temperatures outside the product's labeled storage requirements.
- SUN PHARMACEUTICAL INDUSTRIES INC recalls Spironolactone TabletsFDAPresence of foreign substance: identified as aluminum.
- YF-Vax powder for solution; Cracked vialsHealth CanadaPackaging
- Nostrum Laboratories, Inc. recalls Sucralfate TabletsFDACGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As a result, it cannot monitor the quality program and hence cannot…
- Lupin Pharmaceuticals Inc. recalls Amlodipine and Benazepril HCl Capsules USP 2.5 mg/10 mgFDALabeling: Incorrect or Missing Lot and/or Exp Date: released with wrong expiry date as Feb.2027 instead of Jan.2027
- Strides Pharma, Inc. recalls Cinacalcet Tablets 90 mgFDAFailed Dissolution Specifications.
- FDC Limited recalls Timolol Maleate Ophthalmic Solution USPFDADefective Container: spike of the cap becomes lodged in the nozzle of the product bottle.
- Pfizer Inc. recalls Bicillin L-A (penicllin G benzathine injectable suspension) and 1 moreFDACGMP Deviations; particulates identified during visual inspection
- Hikma Pharmaceuticals USA Inc. recalls Lorazepam InjectionFDAFailed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
- Vagifem® 10: out of specificationHealth CanadaProduct safety
- Mckesson Medical-Surgical Inc. Corporate Office recalls EVENITY and 2 moreFDACGMP Deviations; potential temperature excursions due to transit delays
- Lupin Pharmaceuticals Inc. recalls clomiPRAMINE Hydrochloride Capsules USP 25 mgFDAFailed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation…
- Cipla USA, Inc. recalls Budesonide Inhalation SuspensionFDALack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.
- Imprimis NJOF, LLC recalls Tropicamide-Proparacaine-Phenylephrine-Ketorolac and 1 moreFDASub-Potent Drug: Subpotent assay results during stability testing.
- Fucidin tablet: Out of specificationHealth CanadaProduct quality
- EPINEPHRINE, SODIUM BICARBONATE & DEXTROSE USP INJECTIONS : Possible microbiological contamination.Health CanadaContamination
- Apo-Lisdexamfetamine 30mg : may contain broken capsules and/or loose capsule content.Health CanadaProduct quality
- Ascend Laboratories, LLC recalls Rizatriptan Benzoate TabletsFDACGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.
- Qualgen, LLC recalls Testosterone 200 mg Pellet packaged in 1mL amber vialsFDALabeling: Incorrect or Missing Lot and/or Exp. Date: A printing issue resulted in incorrect lot numbers on the label.
- SUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate CapsulesFDAFailed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability…
- ACCORD HEALTHCARE, INC. recalls Levothyroxine Sodium TabletsFDASubpotent Drug: Assay below the approved specification
- Lupin Pharmaceuticals Inc. recalls Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mgFDAProduct Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets…
- Dr. Reddy's Laboratories, Inc. recalls Omeprazole Delayed-release CapsulesFDAPresence of foreign tablets/capsules: presence of foreign Divalproex Sodium Extended-Release 250mg tablet in a bottle of omeprazole capsules.
- Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles recalls PERIPHERAL PARENTERAL NUTRITIONFDALack of Processing Controls; prescriptions were compounded in an ISO-5 area where it was identified that a daily cleaning step was not sufficiently…
- A.P. Deauville, LLC recalls Power Stick for her PH Balanced Roll-On Antiperspirant Deodorant wi… and 2 moreFDACGMP Deviations